Technique Failure in a Multicenter Canadian Home Hemodialysis Cohort.


Journal

American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075

Informations de publication

Date de publication:
02 2019
Historique:
received: 05 02 2018
accepted: 26 08 2018
pubmed: 6 11 2018
medline: 13 11 2019
entrez: 6 11 2018
Statut: ppublish

Résumé

Increasing uptake of home hemodialysis (HD) has led to interest in characteristics that predict discontinuation of home HD therapy for reasons other than death or transplantation. Recent reports of practice pattern variability led to the hypothesis that there are patient- and center-specific factors that influence these discontinuations. Retrospective cohort study. Incident home HD patients at 7 centers in Canada between 2000 and 2010. Treatment center, case-mix, and process-of-care variables. Technique failure (defined as discontinuation of home HD therapy for any reason other than training failure, death, or transplantation) and mortality. Regression modeling of technique failure using Cox proportional hazard models adjusting for treatment center and modifiable and nonmodifiable patient-level variables, censored for death and transplantation. The cohort consisted of 579 patients. Mean age was 49.9±14.1 years, 74% were of European ancestry, median dialysis vintage was 1.9 (IQR, 0.6-5.2) years, and 68% used an arteriovenous access. Mean duration of dialysis was 31.2±12.6 hours per week. Unadjusted 1- and 2-year technique survival and overall survival were 90% and 83% and 94% and 87%, respectively. Treating center was a strong predictor of technique failure and mortality, with HRs ranging from 0.37 to 5.11 for technique failure (1 of 6 centers with P<0.05 relative to the reference) and 0.17 to 8.73 for mortality (3 of 6 centers with P<0.05 relative to the reference). With baseline adjustment for center, only older age and more than 3 treatments per week remained significant predictors of technique failure, while no individual-level variables remained as significant predictors of survival. Limited statistical power. Home HD treating centers may influence technique failure and patient mortality independent of case-mix. The relationship between processes of care and patient outcomes requires further investigation.

Identifiants

pubmed: 30392981
pii: S0272-6386(18)30939-9
doi: 10.1053/j.ajkd.2018.08.016
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

230-239

Informations de copyright

Copyright © 2018 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Robert P Pauly (RP)

Division of Nephrology, University of Alberta, Edmonton, AB. Electronic address: robert.pauly@ualberta.ca.

Rhonda J Rosychuk (RJ)

Department of Pediatrics, University of Alberta, Edmonton, AB.

Iram Usman (I)

Department of Pediatrics, University of Alberta, Edmonton, AB.

Frances Reintjes (F)

Northern Alberta Renal Program, Alberta Health Services, Edmonton, AB.

Maliha Muneer (M)

Northern Alberta Renal Program, Alberta Health Services, Edmonton, AB.

Christopher T Chan (CT)

Division of Nephrology, University Health Network, University of Toronto, Toronto, ON.

Michael Copland (M)

Division of Nephrology, University of British Columbia, Vancouver, BC.

Robert Lindsay (R)

Division of Nephrology, Western University, London, ON.

Jennifer MacRae (J)

Division of Nephrology, University of Calgary, Calgary, AB.

Gihad Nesrallah (G)

Division of Nephrology, Western University, London, ON.

Andreas Pierratos (A)

Department of Nephrology, Humber River Regional Hospital, Toronto.

Deborah L Zimmerman (DL)

Division of Nephrology, University of Ottawa, Ottawa, ON.

Paul Komenda (P)

Section of Nephrology, University of Manitoba, Winnipeg, MB, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH